TURCHETTI, Giuseppe
 Distribuzione geografica
Continente #
EU - Europa 42.014
NA - Nord America 41.519
AS - Asia 20.138
SA - Sud America 3.597
Continente sconosciuto - Info sul continente non disponibili 598
AF - Africa 501
OC - Oceania 95
AN - Antartide 1
Totale 108.463
Nazione #
US - Stati Uniti d'America 39.137
NL - Olanda 15.160
IT - Italia 7.675
SG - Singapore 7.244
RU - Federazione Russa 5.456
CN - Cina 5.080
GB - Regno Unito 4.707
VN - Vietnam 2.855
BR - Brasile 2.854
DE - Germania 2.400
UA - Ucraina 2.004
CA - Canada 1.472
DK - Danimarca 1.248
HK - Hong Kong 1.149
KR - Corea 1.076
FR - Francia 887
BD - Bangladesh 808
SE - Svezia 663
IN - India 460
FI - Finlandia 408
IE - Irlanda 356
PL - Polonia 314
AR - Argentina 273
MX - Messico 246
ES - Italia 176
ZA - Sudafrica 173
ID - Indonesia 170
TR - Turchia 170
JP - Giappone 166
IQ - Iraq 151
EC - Ecuador 135
CR - Costa Rica 126
EU - Europa 126
IL - Israele 112
PK - Pakistan 89
AT - Austria 86
CO - Colombia 84
AU - Australia 82
PH - Filippine 78
HN - Honduras 73
VE - Venezuela 73
NI - Nicaragua 72
MY - Malesia 68
MA - Marocco 66
GT - Guatemala 65
CH - Svizzera 64
BE - Belgio 62
JM - Giamaica 61
SA - Arabia Saudita 61
TT - Trinidad e Tobago 61
UZ - Uzbekistan 60
LT - Lituania 58
CL - Cile 51
PE - Perù 49
SV - El Salvador 48
PR - Porto Rico 47
GP - Guadalupe 44
PT - Portogallo 43
AE - Emirati Arabi Uniti 40
JO - Giordania 40
CW - ???statistics.table.value.countryCode.CW??? 39
PY - Paraguay 38
EG - Egitto 37
KE - Kenya 34
TN - Tunisia 34
TW - Taiwan 32
RO - Romania 31
TH - Thailandia 30
BG - Bulgaria 27
IR - Iran 25
AZ - Azerbaigian 24
NP - Nepal 23
AL - Albania 21
DO - Repubblica Dominicana 21
ET - Etiopia 21
SK - Slovacchia (Repubblica Slovacca) 20
CZ - Repubblica Ceca 19
DZ - Algeria 19
KZ - Kazakistan 19
UY - Uruguay 18
SN - Senegal 17
GR - Grecia 16
RS - Serbia 16
HU - Ungheria 15
SC - Seychelles 15
BO - Bolivia 14
NG - Nigeria 14
CI - Costa d'Avorio 13
CY - Cipro 13
HR - Croazia 13
ML - Mali 13
LV - Lettonia 12
NZ - Nuova Zelanda 12
OM - Oman 12
PA - Panama 12
PS - Palestinian Territory 12
BA - Bosnia-Erzegovina 11
AO - Angola 10
LB - Libano 10
AM - Armenia 8
Totale 107.852
Città #
Amsterdam 14.946
Dallas 6.237
Singapore 3.778
Southend 3.055
San Jose 2.738
Ashburn 2.695
Beijing 2.123
Chandler 2.063
Council Bluffs 2.063
Woodbridge 1.736
Houston 1.582
Ann Arbor 1.350
San Mateo 1.164
Hong Kong 1.097
Milan 1.093
Moscow 956
Jacksonville 952
Dearborn 842
Daejeon 815
Rome 790
Fairfield 781
The Dalles 763
Ho Chi Minh City 745
Los Angeles 659
Falls Church 630
Cambridge 603
Pisa 581
Wilmington 577
New York 575
Hanoi 494
Seattle 474
Santa Clara 434
Hefei 408
Dong Ket 397
Lauterbourg 394
Boardman 389
Stevenage 379
Portsmouth 357
Montréal 339
São Paulo 337
Lawrence 325
Dublin 322
Phoenix 287
Buffalo 276
Warsaw 267
Munich 264
Brooklyn 258
Seoul 248
Beauharnois 228
Montreal 202
Fremont 191
Columbus 190
Orem 188
Ottawa 179
Figino 153
Chicago 150
Naples 149
Redwood City 147
Florence 145
Turin 145
London 140
Atlanta 139
Denver 137
Salerno 133
Chennai 130
Old Bridge 130
Toronto 129
Tokyo 127
Mexico City 119
Stockholm 117
Bologna 116
San Diego 116
Johannesburg 112
Da Nang 105
Helsinki 102
Poplar 100
San José 97
Mcallen 91
Rio de Janeiro 87
Frankfurt am Main 86
San Francisco 84
Haiphong 82
Tel Aviv 77
Manchester 73
Bari 72
Nuremberg 71
Palermo 71
Boston 70
Managua 69
Guangzhou 65
Ankara 63
Norwalk 62
Wuxi 57
Brasília 55
Genoa 54
Tashkent 54
Serra 53
Biên Hòa 52
Guayaquil 52
Belo Horizonte 51
Totale 70.305
Nome #
L’Economia digitale e il settore assicurativo 2.131
The interaction of public and private systems in healthcare provision 2.063
Il Costo Sociale della Malattia di Alzheimer 2.027
Il Costo Sociale dell’Emicrania 2.024
L’E-Commerce. Le Nuove Frontiere della Distribuzione Assicurativa 2.024
Il governo delle tecnologie per un ammodernamento del Sistema Sanitario 2.019
La qualità della vita di soggetti anziani nelle grandi città e nei piccoli paesi: uno studio comparato sui bisogni dei cittadini in Italia ed in Giappone 2.016
Prevenzione delle cadute da incidente domestico negli anziani 2.016
Innovation in rehabilitation technology: technological opportunities and socio-economic implications 902
Nutri-Score and Food Perception: Insights from an Italian Study 824
A cost-effectiveness analysis for total knee arthroplasty telerehabilitation: proof of concept of a decision model 606
On Robots and Insurance 589
The Effect of using Serifs in Brand Names on Luxury Perception 588
Food literacy and food choice – a survey-based psychometric profiling of consumer behaviour 544
PDTA per la Chirurgia bariatrica: l'esperienza di sei centri italiani 543
A new organizational integrated home-care model: An Italian pilot study 529
The impact of cardiovascular disease and type 2 diabetes mellitus on social cost in chronic kidney disease patients in Italy 475
How deregulation shapes market structure and industry efficiency. The case of the Italian motor insurance industry 470
Economic evaluation of da Vinci-assisted robotic surgery:a systematic review 470
La logistica sanitaria nelle Aziende Sanitarie e Ospedaliere del Servizio Sanitario Nazionale 444
The Evaluative, Economic, and Organizational Dimensions of Personalized Medicine 435
A budget impact analysis (BIA) of the use of paracalcitol for the treatment of a secondary hyperparathyroidism (SHPT) in end stage renal disease patients 426
Acceptability of robotic technology in neuro-rehabilitation: Preliminary results on chronic stroke patients 419
The strength of Nutriscore in improving sustainable eating habits and well-being: bad and good news 417
Early Stage Economic Evaluation of Caretoy System for Early Intervention In Preterm Infants At Risk of Neurodevelopmental Disorders 404
Are The Elderly Citizens Ready for Assisted Living Technologies? an Italian Case Study 398
Cost-effectiveness (CE) of imaging-guided strategies for the diagnosis of coronary artery disease (CAD): results from the EVINCI study 392
An In Silico Health Economic Model Applied to Cryopyrin Associated Periodic Syndromes (Caps): Cost Effectiveness of Prevention Effects of Ultra-Orphan Drugs for Rare Diseases 383
Marketing per la Sanità. Logiche e strumenti 371
Budget impact analysis of belimumab in treating Systemic Lupus Erythematosus 364
Early assessment of neuro-rehabilitation technology: a case study 362
How colour saturation accelerates purchase behaviour, and influences food choice: 359
Comparative health technology assessment of robotic-assisted, direct manual laparoscopic and open surgery: a prospective study 359
Health technology assessment. Evaluation of biomedical innovative technologies 357
Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF 351
A Pitcure of Private Health Insurance Policyholders in Italy 349
Assessment of the Economic Impact of Belimumab for the Treatment of Systemic Lupus Erythematosus in the Italian Setting: A Cost-Effectiveness Analysis 348
Scoping review and bibliometric analysis of Big Data applications for Medication adherence: An explorative methodological study to enhance consistency in literature 347
Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS) 345
Early assessment of neuro-rehabilitation technology 342
Cost analysis of the robotic surgery in Italy 342
Economia e gestione delle imprese di assicurazione 340
The opportunity of treating type II diabetes with DPP4i: an economic evaluation versus conventional treatment in the Italian setting 340
A systematic literature review of the economic impact of ankylosing spondylitis 334
Effectiveness and costs of different strategies for the diagnosis of stable coronary artery disease: results from the EVINCI study 334
Tele-monitoring of ventilator-dependent patients: A European Respiratory Society Statement 332
An economic evaluation of different procedures in bariatric surgery 331
Model-Based Techniques In The Early Phases of The Medical Device Development: A Systematic Literature Review 331
Systematic literature review on economic implications and pharmacoeconomic issues of rheumatoid arthritis 330
A novel explanation of why organizations fail to adopt proven technologies: The special case of imaging in the healthcare sector 330
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 329
Interactive business models for Telerehabilitation after Total Knee Replacement: Preliminary results from Tuscany 329
Early assessment of neuro – rehabilitation technology: a case study 328
A new drug responding an unmet need: belimumab in the treatment of systemic lupus erythematosus 328
Advanced therapies in wound management: cell and tissue based therapies, physical and bio-physical therapies smart and IT based technologies 327
Economic evaluation of the acquisition of a remote monitoring system in the framework of a 'chronic care model' 320
Is EEG Suitable for Marketing Research? A Systematic Review 319
Social costs of different procedures in bariatric surgery in patients with obesity-related comorbidities 318
Assessment of the economic impact of Belimumab for the treatment of systemic lupus erithematosus in the Italian setting: a cost-effectiveness analysis 317
Rare diseases under different levels of economic analysis: current activities, challenges and perspectives 315
Health Technology Assessment Needs Information Technology: The Experience From The First Italian Study On The Da Vinci Surgical Robot 314
Budget impact analysis of the use of extended half-life recombinant factor VIII (Efmoroctog alfa) for the treatment of congenital haemophilia A: The Italian national health system perspective 313
A systematic literature review of existing tools used to assess medication adherence in connective tissue diseases: the state of the art for the future development of co-designed measurement tools 313
Topic modeling and user network analysis on twitter during world lupus awareness day 312
A registry for the collection of data in cochlear implant patients 310
Belimumab nel trattamento del Lupus Eritematoso Sistemico: valutazione di una nuova tecnologia sanitaria 309
Why effectiveness of robot-mediated neuro-rehabilitation does not necessarily influence its adoption? 308
Different strategies for latent TB assessment in patients undergoing anti-TNF treatment: an economic model 308
Innovation in rehabilitation technology: technological opportunities and socio-economic implications 307
Diagnosis and referral of rheumatoid arthritis by primary care physician: results of a pilot study on the city of Pisa, Italy 306
Cost-effectiveness analysis of stand-alone or combined non-invasive imaging tests for the diagnosis of stable coronary artery disease: results from the EVINCI study 306
Comparison of generic, condition-specific and mapped health state utility values for pediatric asthma 305
How to design a business model for technology-driven innovations like robots. The case of Robot-Era 304
Innovation in rehabilitation technology 303
Analisi di budget impact sull’utilizzo di paracalcitolo nel trattamento dell’iperparatiroidismo secondario associato a malattia renale cronica 303
The COVID-19 outbreak: From “black swan” to global challenges and opportunities 302
The cost-effectiveness of drug therapies to treat secondary hyperparathyroidism in renal failure: a focus on evidence regarding paricalcitol and cinacalcet 299
Development of an objective feedback score for the evaluation of drug and medical device manufacturers/distributors as an additional parameter to be considered in public procurement 299
Approaching 2014: Is Telemedicine Assessed from The Social Perspective? A Brief 2013 Systematic Review 297
Economic impact of drug addiction interventions in adult population: The Peru case 297
Natural and man-made disasters: challenges and international perspectives for insurance 296
Alfonso Desiata. L'Assicuratore, l'Intellettuale, la Persona 295
Late chronotypes, late mealtimes. Chrononutrition and sleep habits during the COVID-19 lockdown in Italy 294
Cost-effectiveness of Different Strategies for the Diagnosis of Stable Coronary Artery Disease: Results from the Evinci Study 293
Assessing the value of the use of diagnostic technology: trade offs for GPs 291
Adherence to treatment in Behçet's syndrome: a multi-faceted issue 290
Budget impact analysis of the use of extended half-life recombinant factor VIII (efmoroctocog alfa) for the treatment of congenital haemophilia a: The Italian National Health System perspective 289
Early timing of the use of paricalcitol for the treatment of secondary hyperparathyroidism (SHPT) in chronic kidney patients (CKD): a budget impact analysis (BI) 288
Columbus' egg and the engineer's effect in forecasting solutions adoption 287
Exploring disease perception in Behçet's syndrome: combining a quantitative and a qualitative study based on a narrative medicine approach 287
Post-traumatic stress disorder and post-traumatic stress symptoms in patients with systemic autoimmune diseases during the COVID-19 pandemic 287
2023 update on Italian guidelines for the treatment of type 2 diabetes 287
PADLOck: Thefts of medicines and Hospital Pharmacies' safety. An Italian study 287
The influence of parental Dietary Behaviors, food literacy and chronotype on Children’s eating habits and psychometric factors 286
Allocazione delle Risorse al Sistema della Ricerca e Competitività del Sistema delle Imprese: una Chiave di Lettura 286
Do Socioeconomic Inequalities Impact The Social Cost Of Chronic Kidney Disease In Italy? 286
Sleep quality mediates the effect of chronotype on resilience in the time of COVID-19 286
Cost for Tuberculosis Care in Developed Countries: Which Data for an Economic Evaluation? 284
The cost-effectiveness of diagnostic cardiac imaging for stable coronary artery disease 284
Dentro, attraverso, oltre la crisi: il caso El.En 283
Totale 49.287
Categoria #
all - tutte 480.569
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 480.569


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.167 0 0 0 0 95 95 609 997 311 480 146 434
2022/20234.347 366 365 139 759 552 736 28 338 645 99 185 135
2023/20242.071 230 107 335 92 70 271 220 115 79 75 132 345
2024/202513.881 160 164 856 465 537 1.088 2.179 3.849 1.179 566 1.896 942
2025/202652.246 1.956 5.594 4.216 4.334 4.131 2.434 4.581 1.615 16.823 2.381 1.648 2.533
2026/20277.178 809 1.331 2.103 2.840 95 0 0 0 0 0 0 0
Totale 108.463